Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Magnesium glycerophosphate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Magnesium glycerophos (magnesium 97.2mg (4mmol)) chew tab SF
0905013G0AADEDE
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 3,579 |
|
Neomag (magnesium 97mg (4mmol)) chewable tablets
0905013G0BEAADE
|
Neomag | Magnesium glycerophosphate | Nutrition and Blood | 3,124 |
|
MagnaPhate (magnesium 97.2mg (4mmol)) chewable tablets
0905013G0BBAADE
|
MagnaPhate | Magnesium glycerophosphate | Nutrition and Blood | 2,847 |
|
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) caps
0905013G0AAA4A4
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 1,840 |
|
Magnesium glycerophos (magnesium 97.2mg(4mmol)) chew tab
0905013G0AADDDD
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 1,471 |
|
Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) caps
0905013G0AABMBM
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 1,174 |
|
Mag glycerophos (mag 121.25mg/5ml (5mmol/5ml)) soln
0905013G0AADFDF
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 748 |
|
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) tab
0905013G0AAA2A2
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 384 |
|
YourMAG (magnesium 97.2mg (4mmol)) chewable tablets
0905013G0BFAADD
|
YourMAG | Magnesium glycerophosphate | Nutrition and Blood | 382 |
|
MagnaPhos 97.2mg (4mmol) capsules
0905013G0BGACA4
|
MagnaPhos | Magnesium glycerophosphate | Nutrition and Blood | 346 |
|
MagnaPhos 97.2mg (4mmol) chewable tablets
0905013G0BGABDE
|
MagnaPhos | Magnesium glycerophosphate | Nutrition and Blood | 259 |
|
Mag glycerophos (mag 121.25mg/5ml (5mmol/5ml)) soln SF
0905013G0AADKDK
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 96 |
|
MagnaPhos 121.25mg/5ml (5mmol/5ml) oral solution
0905013G0BGADDF
|
MagnaPhos | Magnesium glycerophosphate | Nutrition and Blood | 94 |
|
Mag glycerophos (mag 97.2mg/5ml (4mmol/5ml)) soln
0905013G0AADCDC
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 93 |
|
MagnaPhos 48.6mg (2mmol) capsules
0905013G0BGAABM
|
MagnaPhos | Magnesium glycerophosphate | Nutrition and Blood | 90 |
|
Mag glycerophos (magnesium 97.2mg/5ml (4mmol/5ml)) soln SF
0905013G0AADJDJ
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 38 |
|
MagnaPhos 97.2mg/5ml (4mmol/5ml) oral solution
0905013G0BGAEDC
|
MagnaPhos | Magnesium glycerophosphate | Nutrition and Blood | 37 |
|
Mag glycerophos (mag 121.25mg/5ml (5mmol/5ml)) susp
0905013G0AADHDH
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 18 |
|
MagnEss Gly 121.25mg/5ml (5mmol/5ml) oral solution
0905013G0BHAFDK
|
MagnEss Gly | Magnesium glycerophosphate | Nutrition and Blood | 16 |
|
LiquaMag GP (magnesium 121.25mg/5ml (5mmol/5ml)) soln
0905013G0BDACDK
|
LiquaMag GP | Magnesium glycerophosphate | Nutrition and Blood | 12 |
|
Mag-4 (magnesium 97.2mg (4mmol)) capsules
0905013G0BCAAA4
|
Mag-4 | Magnesium glycerophosphate | Nutrition and Blood | 10 |
|
Magn glycerophos (mag 97.2mg/5ml (4mmol/5ml)) susp
0905013G0AACZCZ
|
Magnesium glycerophosphate | Magnesium glycerophosphate | Nutrition and Blood | 9 |
|
MagnEss Gly 97.2mg/5ml (4mmol/5ml) oral solution
0905013G0BHAEDJ
|
MagnEss Gly | Magnesium glycerophosphate | Nutrition and Blood | 9 |
|
Mag-4 (magnesium 97.2mg (4mmol)) chewable tablets
0905013G0BCACDE
|
Mag-4 | Magnesium glycerophosphate | Nutrition and Blood | 3 |
|
Mag-4 (magnesium 97.2mg (4mmol)) tablets
0905013G0BCADA2
|
Mag-4 | Magnesium glycerophosphate | Nutrition and Blood | 3 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.